XML 29 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Cash and cash equivalents    
Restricted cash $ 514 $ 544
Securities purchased under resale agreements 0 318
Premises and equipment, accumulated depreciation 9,911 9,850
Other assets, reserves for credit losses 27 22
Liabilities    
Long-term debt $ 47,866 $ 42,573
Shareholders’ Equity    
Preferred shares, par value (in dollars per share) $ 1.667 $ 1.667
Preferred shares, authorized (in shares) 20,000,000 20,000,000
Preferred shares, outstanding (in shares) 1,600 1,600
Preferred shares, issued (in shares) 1,600 1,600
Common shares, par value (in dollars per share) $ 0.20 $ 0.20
Common shares, authorized (in shares) 3,600,000,000 3,600,000,000
Common shares, issued (in shares) 723,000,000 743,000,000
Common shares, outstanding (in shares) 723,000,000 743,000,000
Card Member receivables    
Cash and cash equivalents    
Financing receivables, gross $ 60,411 $ 57,613
Financing receivables, reserves for credit losses 174 229
Card Member loans    
Cash and cash equivalents    
Financing receivables, gross 125,995 107,964
Financing receivables, reserves for credit losses 5,118 3,747
Other loans    
Cash and cash equivalents    
Financing receivables, reserves for credit losses 126 59
Variable Interest Entity, Primary Beneficiary    
Cash and cash equivalents    
Restricted cash 0 5
Restricted investments 66 54
Liabilities    
Long-term debt 13,426 12,662
Variable Interest Entity, Primary Beneficiary | Card Member receivables    
Cash and cash equivalents    
Financing receivables, gross 4,587 5,193
Variable Interest Entity, Primary Beneficiary | Card Member loans    
Cash and cash equivalents    
Financing receivables, gross $ 28,590 $ 28,461